53241-90-0 Usage
General Description
2-[(6-Methoxypyridin-3-ylamino)methylene]malonic acid diethyl ester is a chemical compound with the molecular formula C16H19N2O6. It is an ester of malonic acid and diethyl alcohol, containing a pyridine ring with a methoxy group in position 6 and an amino group in position 3. 2-[(6-METHOXYPYRIDIN-3-YLAMINO)METHYLENE]MALONIC ACID DIETHYL ESTER is often used as a building block in organic synthesis, particularly in the production of pharmaceuticals and agrochemicals. It has potential applications in medicinal chemistry and drug discovery due to its structural features and reactivity. However, it is important to handle this chemical with caution, as it may pose health and environmental risks if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 53241-90-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,2,4 and 1 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 53241-90:
(7*5)+(6*3)+(5*2)+(4*4)+(3*1)+(2*9)+(1*0)=100
100 % 10 = 0
So 53241-90-0 is a valid CAS Registry Number.
53241-90-0Relevant articles and documents
ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY
-
Page/Page column 128-129, (2016/07/05)
The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.
Synthesis and structure-activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors
Gewald, Rainer,Rueger, Carla,Grunwald, Christian,Egerland, Ute,Hoefgen, Norbert
scheme or table, p. 6652 - 6656 (2011/12/04)
The synthesis and SAR studies of a series of structurally novel inhibitors of PDE7 are discussed. The best compounds from the series display low nanomolar inhibitory activity and are selective versus other PDE isoenzymes.
Antibacterial Agents
-
Page/Page column 9, (2008/12/07)
Naphthalene, quinoline, quinoaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
